Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217 ; volume:16 ; number:1 ; day:8 ; month:2 ; year:2024 ; pages:1-10 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (8.2.2024), 1-10, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01391-1
- URN
-
urn:nbn:de:101:1-2404170724278.030973064101
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bali, Divya
- Hansson, Oskar
- Janelidze, Shorena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Novel insights regarding the measurement properties of the SCOPA-AUT
Fluid biomarkers in Alzheimer’s disease – current concepts
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
Factors associated with fear of falling in people with Parkinson’s disease
The clinical significance of 10-m walk test standardizations in Parkinson’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Novel insights regarding the measurement properties of the SCOPA-AUT
Fluid biomarkers in Alzheimer’s disease – current concepts
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
Factors associated with fear of falling in people with Parkinson’s disease
The clinical significance of 10-m walk test standardizations in Parkinson’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Novel insights regarding the measurement properties of the SCOPA-AUT
Fluid biomarkers in Alzheimer’s disease – current concepts
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
Factors associated with fear of falling in people with Parkinson’s disease